Re: “Letter to the Editor: Repurposing of an Antisepsis Drug in COVID-19 Patients,” by Kumar et al. (doi: 10.1089/adt.2020.994)
ASSAY and Drug Development Technologies, Ahead of Print.
Source: ASSAY and Drug Development Technologies - Category: Drugs & Pharmacology Authors: Rajni Rani Source Type: research
More News: COVID-19 | Drugs & Pharmacology